| Abstract: | Datamonitor's CEL-SCI Corporation Company Profile is the essential source for top-level company data and information. CEL-SCI Corporation Company Profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
CEL-SCI Corporation (CEL-SCI) is a biotechnology company engaged in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The company's core activities include: drug discovery, research, development and manufacturing of complex biological substances. The company primarily operates in the US, where it is headquartered in Vienna, Virginia and employs about 30 people. The company recorded revenues of $5.1 thousand in the fiscal year ended December 2008, a decrease of 91.1% over 2007. The company's operating loss was $9,512.3 thousand in fiscal year 2008, as compared to the operating loss of $9,352.2 thousand in 2007. Its net loss was $7,703.4 thousand in fiscal year 2008, as compared to the net loss of $9,629.7 thousand in 2007.
Scope of the Report
- Provides all the crucial information on CEL-SCI Corporation required for business and competitor intelligence needs
-Data is supplemented with details on CEL-SCI Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from CEL-SCI Corporation
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
|
